Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:9522671rdf:typepubmed:Citationlld:pubmed
pubmed-article:9522671lifeskim:mentionsumls-concept:C0324145lld:lifeskim
pubmed-article:9522671lifeskim:mentionsumls-concept:C0004057lld:lifeskim
pubmed-article:9522671lifeskim:mentionsumls-concept:C0034656lld:lifeskim
pubmed-article:9522671lifeskim:mentionsumls-concept:C0040038lld:lifeskim
pubmed-article:9522671lifeskim:mentionsumls-concept:C0040223lld:lifeskim
pubmed-article:9522671lifeskim:mentionsumls-concept:C0025803lld:lifeskim
pubmed-article:9522671lifeskim:mentionsumls-concept:C0031928lld:lifeskim
pubmed-article:9522671lifeskim:mentionsumls-concept:C1708528lld:lifeskim
pubmed-article:9522671lifeskim:mentionsumls-concept:C0023981lld:lifeskim
pubmed-article:9522671lifeskim:mentionsumls-concept:C1561560lld:lifeskim
pubmed-article:9522671lifeskim:mentionsumls-concept:C1561561lld:lifeskim
pubmed-article:9522671lifeskim:mentionsumls-concept:C1547135lld:lifeskim
pubmed-article:9522671lifeskim:mentionsumls-concept:C1547139lld:lifeskim
pubmed-article:9522671lifeskim:mentionsumls-concept:C0528332lld:lifeskim
pubmed-article:9522671lifeskim:mentionsumls-concept:C0439841lld:lifeskim
pubmed-article:9522671pubmed:issue1lld:pubmed
pubmed-article:9522671pubmed:dateCreated1998-4-28lld:pubmed
pubmed-article:9522671pubmed:abstractTextFrom March 1994 to March 1996, 287 patients, presenting with lower extremity injuries, who required immobilizing bandages or casts, where included in a prospective, randomized study. These patients received either low-molecular heparin or acetylsalicylic acid for thrombosis prophylaxis. In all patients a clinical examination and a colour-coded duplex sonography were performed after removal of the cast for detection of lower extremity venous thrombosis. A plebography was performed when thrombosis was suspected. A subcutaneous injection of divarin 1750 was given once daily in 143 patients. Thrombosis prophylaxis with Aspirin 2 x 500 mg administered orally was performed in 144 patients. Deep vein thrombosis occurred in 9 patients (6.3%) with clivarin prophylaxis and in 7 patients (4.8%) treated with Aspirin. In both groups, no clinically significant side effects of the medications were observed.lld:pubmed
pubmed-article:9522671pubmed:languagegerlld:pubmed
pubmed-article:9522671pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9522671pubmed:citationSubsetIMlld:pubmed
pubmed-article:9522671pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9522671pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9522671pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9522671pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9522671pubmed:statusMEDLINElld:pubmed
pubmed-article:9522671pubmed:monthJanlld:pubmed
pubmed-article:9522671pubmed:issn0177-5537lld:pubmed
pubmed-article:9522671pubmed:authorpubmed-author:GotzenLLlld:pubmed
pubmed-article:9522671pubmed:authorpubmed-author:LeferingRRlld:pubmed
pubmed-article:9522671pubmed:authorpubmed-author:HessmannMMlld:pubmed
pubmed-article:9522671pubmed:authorpubmed-author:AchenbachSSlld:pubmed
pubmed-article:9522671pubmed:authorpubmed-author:GehlingHHlld:pubmed
pubmed-article:9522671pubmed:authorpubmed-author:GiannadakisKKlld:pubmed
pubmed-article:9522671pubmed:issnTypePrintlld:pubmed
pubmed-article:9522671pubmed:volume101lld:pubmed
pubmed-article:9522671pubmed:ownerNLMlld:pubmed
pubmed-article:9522671pubmed:authorsCompleteYlld:pubmed
pubmed-article:9522671pubmed:pagination42-9lld:pubmed
pubmed-article:9522671pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:9522671pubmed:meshHeadingpubmed-meshheading:9522671-...lld:pubmed
pubmed-article:9522671pubmed:meshHeadingpubmed-meshheading:9522671-...lld:pubmed
pubmed-article:9522671pubmed:meshHeadingpubmed-meshheading:9522671-...lld:pubmed
pubmed-article:9522671pubmed:meshHeadingpubmed-meshheading:9522671-...lld:pubmed
pubmed-article:9522671pubmed:meshHeadingpubmed-meshheading:9522671-...lld:pubmed
pubmed-article:9522671pubmed:meshHeadingpubmed-meshheading:9522671-...lld:pubmed
pubmed-article:9522671pubmed:meshHeadingpubmed-meshheading:9522671-...lld:pubmed
pubmed-article:9522671pubmed:meshHeadingpubmed-meshheading:9522671-...lld:pubmed
pubmed-article:9522671pubmed:meshHeadingpubmed-meshheading:9522671-...lld:pubmed
pubmed-article:9522671pubmed:meshHeadingpubmed-meshheading:9522671-...lld:pubmed
pubmed-article:9522671pubmed:meshHeadingpubmed-meshheading:9522671-...lld:pubmed
pubmed-article:9522671pubmed:meshHeadingpubmed-meshheading:9522671-...lld:pubmed
pubmed-article:9522671pubmed:meshHeadingpubmed-meshheading:9522671-...lld:pubmed
pubmed-article:9522671pubmed:meshHeadingpubmed-meshheading:9522671-...lld:pubmed
pubmed-article:9522671pubmed:meshHeadingpubmed-meshheading:9522671-...lld:pubmed
pubmed-article:9522671pubmed:meshHeadingpubmed-meshheading:9522671-...lld:pubmed
pubmed-article:9522671pubmed:meshHeadingpubmed-meshheading:9522671-...lld:pubmed
pubmed-article:9522671pubmed:year1998lld:pubmed
pubmed-article:9522671pubmed:articleTitle[Prospective randomized pilot study of ambulatory prevention of thromboembolism. 2 times 500 mg aspirin (ASS) vs. clivarin 1750 (NMH)].lld:pubmed
pubmed-article:9522671pubmed:affiliationKlinik für Unfallchirurgie, Philipps-Universität Marburg.lld:pubmed
pubmed-article:9522671pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:9522671pubmed:publicationTypeClinical Triallld:pubmed
pubmed-article:9522671pubmed:publicationTypeComparative Studylld:pubmed
pubmed-article:9522671pubmed:publicationTypeEnglish Abstractlld:pubmed
pubmed-article:9522671pubmed:publicationTypeRandomized Controlled Triallld:pubmed